GEN-Thermo_Oct22_MakingThePromiseOf - 24

Smart Vaccine Manufacturing Technologies Look Set to Stay
Smart Vaccine Manufacturing
Technologies Look Set to Stay
mRNA based vaccines
emerged as a winner
partly as a result of
smart manufacturing
technologies. Use of these
systems will continue to
grow as industry develops
vaccines for a wide range
of contagious diseases.
Getty Images: Manjurul
So called " smart " vaccine manufacturing technologies,
i.e., systems that gather and exchange process
data, have been vital in the battle against COVID19.
The availability of higher quality data helped
industry accelerate process development and start
making billions of doses of vaccine less than a year
after SARS-CoV-2, the virus that causes COVID-19,
was sequenced.
To put this in context, before 2019, vaccine development,
from discovery, through clinical trials, process
development, and manufacturing, took an average of
10 to 15 years, according to an analysis by the International
Federation of Pharmaceutical Manufacturers
& Associations (IFPMA), a trade association.
24 | GENengnews.com
For Vishnu Kumar Ph.D. from Pennsylvania State
University, the speed with which the vaccine
industry adopted smart manufacturing technologies
was the most impressive part of its response to
the pandemic.
" The rapid spread of COVID-19 across the globe
created an urgent need to save people's lives and
livelihoods. It was recognized, quite early, by the
healthcare experts that vaccines were the best way
out of the crisis, " he says. " As a result of the pandemic,
biopharma firms quickly adopted novel biotechnology
platform-based techniques for vaccine
manufacturing such as mRNA and viral vector platform-based
vaccines. "

https://www.genengnews.com https://www.genengnews.com

GEN-Thermo_Oct22_MakingThePromiseOf

Table of Contents for the Digital Edition of GEN-Thermo_Oct22_MakingThePromiseOf